Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

Majd A. El-Harasis; Christopher V. DeSimone; Xiaoxi Yao; Peter A. Noseworthy

doi:10.1016/j.ccl.2019.01.010

Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

Majd A. El-Harasis, Christopher V. DeSimone, Xiaoxi Yao, Peter A. Noseworthy

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

Original language	English (US)
Pages (from-to)	221-230
Number of pages	10
Journal	Cardiology clinics
Volume	37
Issue number	2
DOIs	https://doi.org/10.1016/j.ccl.2019.01.010
State	Published - May 2019

Keywords

Atrial fibrillation
Cardiac resynchronization therapy
Catheter ablation
Heart failure

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ccl.2019.01.010

Cite this

@article{dd02edbd35b24974a45237b3888fd261,

title = "Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure",

abstract = "Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.",

keywords = "Atrial fibrillation, Cardiac resynchronization therapy, Catheter ablation, Heart failure",

author = "El-Harasis, {Majd A.} and DeSimone, {Christopher V.} and Xiaoxi Yao and Noseworthy, {Peter A.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = may,

doi = "10.1016/j.ccl.2019.01.010",

language = "English (US)",

volume = "37",

pages = "221--230",

journal = "Cardiology clinics",

issn = "0733-8651",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

AU - El-Harasis, Majd A.

AU - DeSimone, Christopher V.

AU - Yao, Xiaoxi

AU - Noseworthy, Peter A.

PY - 2019/5

Y1 - 2019/5

N2 - Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

AB - Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

KW - Atrial fibrillation

KW - Cardiac resynchronization therapy

KW - Catheter ablation

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=85061304439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061304439&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2019.01.010

DO - 10.1016/j.ccl.2019.01.010

M3 - Review article

C2 - 30926023

AN - SCOPUS:85061304439

SN - 0733-8651

VL - 37

SP - 221

EP - 230

JO - Cardiology clinics

JF - Cardiology clinics

IS - 2

ER -

Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this